Doctoral dissertations supervised/co-supervised by/carried out in collaboration with the researchers at the Department of Clinical Pharmacology, University of Helsinki.
2018
2017
2016
2015
2014
2012
2011
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
- Teemu Kantola, Effects of itraconazole and some other CYP3A4 inhibitors on the pharmacokinetics of HMG-CoA reductase inhibitors.
- Vilja Palkama, Studies on drug interactions between CYP3A4 inhibitors and anaesthetic drugs.
- Kirsti Villikka, Studies on drug interactions caused by rifampicin and dexamethasone in humans.
1998
- Tommi Lamberg, Effects of inhibition and induction of CYP3A4 on the pharmacokinetics and pharmacodynamics of buspirone.
1997
- Mirja Hämäläinen, L: Optimal drug treatment of recurrent headaches and migraine in children – a clinical and pharmacological study.
- Kirsi-Maija Kaukonen, Studies on the effects of a CYP3A4-inhibitor, itraconazole, on the pharmacokinetics and pharmacodynamcis of cardiovascular drugs.
- Seppo Kähkönen, Pharmacodynamic and pharmacokinetic aspects of propranolol, verapamil and isosorbide dinitrate during alcohol withdrawal.
- Eeva Lukkari, Clinical pharmacology of oxybutynin, with special reference to pharmacokinetics and interaction.
1996
- Reijo Laaksonen, The effect of HMG-CoA reductase inhibitor treatment on serum and skeletal muscle ubiquinone.
- Jouni Ahonen, Studies on CYP3A mediated drug interactions in anaesthesiology.
- Ari Illi, Inhibition of catechol-O-methyltransferase by entacapone: Effects on haemodynamics and catecholamine metabolism and interactions with drugs interfering with catecholamine disposition.
- Harri Luurila, Effect of erythromycin on the pharmacokinetics and pharmacodynamics of hypnotics.
- Anu Varhe, Interactions of triazolam with inhibitors of CYP3A enzymes.
1995
- Janne Backman, Effects of drugs inhabiting and inducing CYP3A enzymes on the pharmacokinetics and pharmacodynamics of oral midazolam.
1994
1993
1990
- Riitta Tokola, Studies on drug absorption and efficacy in migraine attacks.
1989
1987
- Kalle Hoppu, Paediatric clinical pharmacology of trimethoprim.
1987
- Eero Tiula, Effect of renal diseases on serum protein binding of drugs.
1985
- Klaus Olkkola, Factors affecting the antidotal efficacy of oral activated charcoal.
1982
- Jaakko-Juhani Himberg, Optimization and validation of gas-chromatographic drug assays for pharmacokinetic studies.
1981
1980
- Sirkka Elfving, Studies on the naturally occurring goitrogen 5-vinyl-2-thiooxazolidone – metabolism and antithyroid effect in the rat.